Achieve Life Sciences is trading 5.51% up now at $8.38 after no clearly reported company-specific catalyst emerged for August 25, 2026.
- Latest material announcements were second-quarter results and business updates on August 11, including financing plans.
- A $150 million at-the-market program was announced August 14.
- The Nasdaq Composite was up 0.97% pre-market; the move appears driven by limited liquidity and market tone rather than fresh company news.